|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Just_Biotherapeutics
Oxford Drug Design
Krebsforschung Heidelberg Gmb H
|
|
gptkbp:awards
|
Top 100 Global Innovators (2021)
Top 10 Biotech Companies (2020)
Best Contract Research Organization (2019)
Best Employer in Germany (2021)
Best Place to Work (2022)
|
|
gptkbp:ceo
|
gptkb:Dr._Werner_Lanthaler
|
|
gptkbp:collaborations
|
gptkb:legislation
academic institutions
research organizations
|
|
gptkbp:employees
|
over 3,000
|
|
gptkbp:focus
|
gptkb:physicist
gptkb:drug
manufacturing
biologics
biopharmaceuticals
medicinal chemistry
small molecules
commercialization
regulatory affairs
clinical development
preclinical development
|
|
gptkbp:founded
|
gptkb:1993
|
|
gptkbp:founder
|
gptkb:Dr._Werner_Lanthaler
|
|
gptkbp:headquarters
|
gptkb:Hamburg,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Evotec SE
|
|
gptkbp:industry
|
gptkb:drug
|
|
gptkbp:market_cap
|
€3 billion (2021)
|
|
gptkbp:partnerships
|
gptkb:Sanofi
gptkb:Boehringer_Ingelheim
gptkb:Bristol-Myers_Squibb
|
|
gptkbp:research_areas
|
oncology
rare diseases
autoimmune diseases
neuroscience
cardiovascular diseases
infectious diseases
metabolic diseases
|
|
gptkbp:revenue
|
€300 million (2020)
|
|
gptkbp:services
|
gptkb:project
drug discovery
|
|
gptkbp:stock_exchange
|
gptkb:Frankfurt_Stock_Exchange
|
|
gptkbp:subsidiary
|
gptkb:Evotec_(UK)_Limited
gptkb:Evotec_(France)_SAS
gptkb:Evotec_(Germany)_Gmb_H
Evotec (US) Inc.
|
|
gptkbp:website
|
www.evotec.com
|
|
gptkbp:bfsParent
|
gptkb:Evotec_(UK)_Limited
gptkb:Evotec_(France)_SAS
gptkb:Evotec_(Germany)_Gmb_H
|
|
gptkbp:bfsLayer
|
4
|